Lucintel Forecasts The Rotavirus Vaccine Market In United States To Reach $18 Billion By 2031

By Author: Lucintel LLC
Total Articles: 7339
Comment this article

According to a market report by Lucintel, the future of the rotavirus vaccine market in United States looks promising with opportunities in the hospital and clinic, academic, and research markets. The rotavirus vaccine market in United States is expected to reach an estimated $18 billion by 2031 with a CAGR of 10.1% from 2025 to 2031. The major drivers for this market are the increasing cases and mortality of rotavirus infection and the rising awareness about the benefits of rotavirus vaccines among healthcare professionals and parents/caregivers.
A more than 150-page report to understand trends, opportunity and forecast in rotavirus vaccine market in United States to 2031 by type (Rotarix, rotateq, rotavin-m1, lanzhou lamb, and others), and end use (hospitals and clinics, academic and research, and others).
Download sample by clicking on rotavirus vaccine market in United States.
Lucintel forecasts that, within the type category, Rotarix is expected to witness the highest growth over the forecast period due to its early approval and launch, global reach, strong clinical evidence, and good safety profile.
...
... Within the end use category, hospitals and clinics will remain the largest segment because they have the necessary infrastructure and expertise to safely and effectively administer rotavirus vaccines.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Rotavirus Vaccine Market in Australia
Rotavirus Vaccine Market in Brazil
Rotavirus Vaccine Market in Canada
Rotavirus Vaccine Market in Mexico
Rotavirus Vaccine Market in Saudi Arabia
Rotavirus Vaccine Market in South Africa